PRESS RELEASE published on 07/24/2025 at 08:00, 1 year 3 months ago vVARDIS’ Drill-Free Solution Curodont™ Has Treated Over One Million Teeth in 18 Months and Is the Fastest Growing Dental Care Product in Its Category vVARDIS' Curodont™ drill-free solution has treated over one million teeth in 18 months, elevating caries management standards. Clinical experts praise it as a revolutionary advancement in dentistry Innovation Dental Care VVARDIS Curodont™ Caries Management
PRESS RELEASE published on 07/24/2025 at 08:00, 1 year 3 months ago TRILOGIQ - Comptes consolidés annuels au 31 mars 2025 Trilogiq publie ses comptes consolidés annuels au 31 mars 2025, avec un chiffre d'affaires de 23.203 K€ et un excédent brut d'exploitation de 1.223 K€, marqués par une légère baisse et une optimisation des coûts Chiffre D'affaires Baisse Comptes Consolidés Excédent Brut D'Exploitation TRILOGIQ
PRESS RELEASE published on 07/24/2025 at 07:56, 1 year 3 months ago AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS AB Science receives approval from European countries to initiate Phase 3 study of masitinib in ALS following protocol validation by EMA and FDA Phase 3 Study ALS AB Science Masitinib EMA
PRESS RELEASE published on 07/24/2025 at 07:56, 1 year 3 months ago AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l’étude confirmatoire de phase 3 avec le masitinib dans la SLA AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l'étude confirmatoire de phase 3 avec le masitinib dans la sclérose latérale amyotrophique. Protocole validé par l'EMA et autorisation de la FDA AB Science Masitinib Sclérose Latérale Amyotrophique Étude Confirmatoire Autorisation Européenne
PRESS RELEASE published on 07/24/2025 at 07:37, 1 year 3 months ago Résultats du premier semestre 2025
PRESS RELEASE published on 07/24/2025 at 07:30, 1 year 3 months ago Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris. La société de biotechnologie se concentre sur le développement de traitements pour les maladies inflammatoires chroniques Euronext Paris Biotechnologie Abivax Traitements Thérapeutiques Suspension Temporaire
PRESS RELEASE published on 07/24/2025 at 07:30, 1 year 3 months ago Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris. La suspension intervient dans le cadre de l'Offre d'American Depositary Shares Euronext Paris Biotechnologie Abivax Offre Publique Suspension Temporaire
PRESS RELEASE published on 07/24/2025 at 07:30, 1 year 3 months ago Abivax announces temporary trading halt of its ordinary shares on Euronext Paris Abivax announces temporary trading halt of its ordinary shares on Euronext Paris due to public offering preparations Euronext Paris Abivax Trading Halt Public Offering Clinical-stage Biotechnology
PRESS RELEASE published on 07/24/2025 at 07:30, 1 year 3 months ago Vossloh achieves high sales and EBIT growth in the second quarter of 2025 Vossloh reports high sales and EBIT growth in Q2 2025, with a 13.5% sales increase and 18.9% EBIT rise, affirming growth outlook for the year Sales Growth Order Backlog Vossloh EBIT Growth Q2 2025
PRESS RELEASE published on 07/24/2025 at 07:10, 1 year 3 months ago AMAG Austria Metall AG: Broad set-up enabled solid half-year results 2025 AMAG Austria Metall AG reports solid half-year results for 2025 despite challenges like US tariffs and cost increases, with revenues growing by +11.1% to EUR 786.2 million Revenues EBITDA Half-year Results AMAG Austria Metall AG US Tariffs
Published on 11/06/2026 at 22:15, 1 day 17 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 2 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 3 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 3 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/08/2026 at 12:10, 3 hours 41 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 5 hours 36 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 2 hours ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 1 day 19 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 1 day 19 hours ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:06, 1 day 20 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 1 day 20 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 1 day 20 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 1 day 20 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL